Pre-Eclampsia Clinical Trial
Official title:
Correlation Between Changes in Liver Stiffness and Preeclampsia as Shown by Fibroscan
Compare the Fibroscan results of preeclamptic women to normal controls and to find out if the
changes are reversible after labor.
Materials and Methods
The purpose of the study is to compare the Fibroscan results of preeclamptic women to normal
controls and to find out if the changes are reversible after labor.
Materials and Methods This prospective observational case-control study will include 50 women
admitted to the fetal-maternal Unit at 24 - 41 weeks gestation and diagnosed with mild/severe
preeclampsia. Preeclampsia is diagnosed as a new onset of hypertension over 140/90, at least
two measurements at least four hours apart, and proteinuria (≥+1 in dipstick or >300 mg/24
hr) after 20 weeks of gestation in a previously normotensive woman.
A control group will consist 100 normotensive women with normal pregnancy outcomes who were
admitted to our fetal-maternal unit during the same period. Demographic, clinical, laboratory
and sonographic data for the women participating will be collected from their chart. All
patients diagnosed with preeclampsia will undergo the following workup: sign and symptoms
evaluation, blood pressure follow up, 24-hour protein excretion in grams per day, complete
blood count, hepatic function test: AST, ALT and coagulation study, HBA1C, coagulation
function test and fibrotest. The Fibroscan test will be performed by a trained hepatologist,
who was blind to the women diagnosis. The fibroscan test will be done during the admission
after the diagnosis of preeclampsia, after delivery and 6 weeks post-partum.
Commonly used cutoffs are >7 kPa for significant fibrosis. Statistical analysis will be
performed with SPSS using Mann Whitney test. Continuous variables will be analyzed using the
student's T test and categorical variables were analyzed using 2. Statistical significance
was set at a P value of < 0.05. The local institutional review board approved this study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03650790 -
C1q/TNF-related Protein 9 (CTRP 9) Level in Preeclamptic Obese and Non-obese Pregnancies
|
N/A | |
Recruiting |
NCT03605511 -
TTP and aHUS in Complicated Pregnancies
|
||
Not yet recruiting |
NCT03302260 -
Identifying Methods for Postpartum Reduction of Vascular Events: Pilot Randomized Controlled Trial
|
N/A | |
Completed |
NCT02911701 -
Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features
|
Phase 4 | |
Completed |
NCT01911494 -
Community Level Interventions for Pre-eclampsia
|
N/A | |
Terminated |
NCT02025426 -
Phenylephrine Versus Ephedrine in Pre-eclampsia
|
Phase 4 | |
Completed |
NCT01352234 -
Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia
|
Phase 4 | |
Active, not recruiting |
NCT02031393 -
Establishing First Trimester Markers for the Identification of High Risk Twin
|
N/A | |
Terminated |
NCT00141310 -
Sildenafil Citrate for the Treatment of Established Pre-Eclampsia
|
Phase 2 | |
Completed |
NCT00157521 -
L-Arginine in Pre-Eclampsia
|
Phase 3 | |
Completed |
NCT04795154 -
Prenatal Yoga as Complementary Therapy of Preeclampsia
|
N/A | |
Completed |
NCT00004399 -
Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia
|
N/A | |
Completed |
NCT00005207 -
Renin and Prorenin in Pregnancy
|
N/A | |
Recruiting |
NCT04551807 -
Natural Versus Programmed Frozen Embryo Transfer (NatPro)
|
Phase 3 | |
Terminated |
NCT04092829 -
Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer
|
N/A | |
Recruiting |
NCT06067906 -
Weight Loss Following an Episode of Pre-eclampsia Using a Dissociated or Hypocaloric Diet in Overweight or Obese Patients
|
N/A | |
Recruiting |
NCT06317467 -
Role of Anti-C1q Autoantibodies in Pregnancy
|
||
Completed |
NCT02218931 -
ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes
|
N/A | |
Active, not recruiting |
NCT04484766 -
Preeclampsia Associated Vascular Aging
|
||
Completed |
NCT03509805 -
Sleep Apnea Syndrome in Obese Women During Pregnancy
|
N/A |